The rollout of Biogen’s Alzheimer’s disease drug has picked up steam — but the company says don’t expect to see big revenue growth in 2024.
Source link
La Potencia Mas Caliente
May 4, 2024
- Santander commercial lending chief: 'We're going to be very disciplined'
- Tres expresidentes latinoamericanos piden ayuda urgente para Haití: “Es una herida abierta”
- NYC says half of arrests at campus protests involved non-students : NPR
- University leaders face calls for accountability after crackdowns on pro-Palestinian encampments
Headlines